Literature DB >> 21097933

Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Ellen Y T Chien1, Wei Liu, Qiang Zhao, Vsevolod Katritch, Gye Won Han, Michael A Hanson, Lei Shi, Amy Hauck Newman, Jonathan A Javitch, Vadim Cherezov, Raymond C Stevens.   

Abstract

Dopamine modulates movement, cognition, and emotion through activation of dopamine G protein-coupled receptors in the brain. The crystal structure of the human dopamine D3 receptor (D3R) in complex with the small molecule D2R/D3R-specific antagonist eticlopride reveals important features of the ligand binding pocket and extracellular loops. On the intracellular side of the receptor, a locked conformation of the ionic lock and two distinctly different conformations of intracellular loop 2 are observed. Docking of R-22, a D3R-selective antagonist, reveals an extracellular extension of the eticlopride binding site that comprises a second binding pocket for the aryl amide of R-22, which differs between the highly homologous D2R and D3R. This difference provides direction to the design of D3R-selective agents for treating drug abuse and other neuropsychiatric indications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097933      PMCID: PMC3058422          DOI: 10.1126/science.1197410

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  34 in total

1.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

Review 2.  The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

Authors:  Lei Shi; Jonathan A Javitch
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

3.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.

Authors:  L Shi; M M Simpson; J A Ballesteros; J A Javitch
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

4.  Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments.

Authors:  M M Simpson; J A Ballesteros; V Chiappa; J Chen; M Suehiro; D S Hartman; T Godel; L A Snyder; T P Sakmar; J A Javitch
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

5.  Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.

Authors:  J A Ballesteros; A D Jensen; G Liapakis; S G Rasmussen; L Shi; U Gether; J A Javitch
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

Review 6.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

7.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.

Authors:  Ron O Dror; Daniel H Arlow; David W Borhani; Morten Ø Jensen; Stefano Piana; David E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-03       Impact factor: 11.205

10.  N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.

Authors:  Amy Hauck Newman; Peter Grundt; George Cyriac; Jeffrey R Deschamps; Michelle Taylor; Rakesh Kumar; David Ho; Robert R Luedtke
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more
  418 in total

1.  Scaffold hopping for identification of novel D(2) antagonist based on 3D pharmacophore modelling of illoperidone analogs.

Authors:  Radha Charan Dash; Sharad H Bhosale; Suhas M Shelke; Mugdha R Suryawanshi; Ashish M Kanhed; Kakasaheb R Mahadik
Journal:  Mol Divers       Date:  2011-12-08       Impact factor: 2.943

2.  Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.

Authors:  Guiying Cui; Binlin Song; Hussein W Turki; Nael A McCarty
Journal:  Pflugers Arch       Date:  2011-12-13       Impact factor: 3.657

3.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

4.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

5.  Comprehensive analysis of host gene expression in Autographa californica nucleopolyhedrovirus-infected Spodoptera frugiperda cells.

Authors:  Tamer Z Salem; Fengrui Zhang; Yan Xie; Suzanne M Thiem
Journal:  Virology       Date:  2011-01-28       Impact factor: 3.616

6.  The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes.

Authors:  D I Cho; C Min; K S Jung; S Y Cheong; M Zheng; S J Cheong; M H Oak; J H Cheong; B K Lee; K M Kim
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Authors:  Gene L Garcia; Maoqing Dong; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

8.  Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode.

Authors:  Dany Fillion; Jérôme Cabana; Gaétan Guillemette; Richard Leduc; Pierre Lavigne; Emanuel Escher
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  Crystallization and preliminary X-ray crystallographic analysis of sterol transcription factor Upc2 from Saccharomyces cerevisiae.

Authors:  Subin Ha; Junsen Tong; Huiseon Yang; Hyung-Seop Youn; Soo Hyun Eom; Young Jun Im
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-01-31

10.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.